Study identifies risk factors for cataracts in patients with diabetes mellitus

News
Article

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

Physician pricking finger with glucose meter on blue backdrop Image credit: ©KaterynaNovikova - adobe.stock.com

Image credit: AdobeStock/KaterynaNovikova

A research team from Romania identified a higher risk of cataract development in patients with diabetes mellitus (DM) who have had the disease for an extended period and who have had poor glycemic control in conjunction with systemic comorbidities,1 according to first author Adriana Ivanescu. She is from the Department of Second Internal Medicine Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, “Victor Babes” University of Medicine and Pharmacy; and the Opticlass Ophthalmology Clinic, both in Timisoara, Romania.

Because DM is a well-known cause of visual loss, the researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM. “Considering the significant impact of cataracts on the quality of life of patients with diabetes, this study aimed to investigate the most important risk factors involved in cataract development to sensitize physicians to the importance of screening and early detection of cataracts and overall health among these patients,” the investigators stated.

A total of 319 patients with a diagnosis of DM were included in the study. The investigators analyzed the patient data retrieved from the medical charts that included the DM status, metabolic control, demographic and anthropometric indices, and generally associated comorbidities.

Data analysis

The authors reported studying the risk factors of hypertension, cardiovascular disease (CVD), chronic kidney disease (CKD), diabetic polyneuropathy (DPN), dyslipidemia, and hepatic steatosis, which were present in all the study patients.

The factors identified in the patients with cataract were the high prevalence rates of hypertension (67.6%), DPN (53.3%), and dyslipidemia (46.6%).

Among them, CKD (p < 0.001) and DPN (p = 0.019) were significant predictive factors for the probability of cataract development.

An ophthalmologic evaluation showed that diabetic retinopathy (DR) reached significance in the occurrence of cataracts. In addition, patient age and DM-related factors, such as disease duration (p < 0.001) and hemoglobin A1c values (p = 0.029), significantly increased the risk of cataracts. Smoking was self-reported by 24.8% of the patients, which also was related significantly to the occurrence of cataracts (p = 0.04).

The investigators concluded, “Our findings are consistent with those in the current literature, emphasizing that poor glycemic control and extended DM duration are the most critical risk factors for cataract development in patients with diabetes. Patients with DM are known to present with multiple associated pathologies such as hypertension, CVD, CKD, DPN, hepatic steatosis, and dyslipidemia. The present study identified CKD and DPN as the most influential comorbidities on cataract occurrence and development, whereas hepatic steatosis was linked to nuclear sclerotic cataracts. While maintaining optimal glycemic control remains a cornerstone strategy for preventing ophthalmological complications in patients with DM, early detection and management of all risk factors prevents the occurrence of vision-threatening cataracts and aids healthcare providers in obtaining better patient-related outcomes.”

Reference:
  1. Ivanescu A, Popescu S, Gaita L, et al. Risk factors for cataracts in patients with diabetes mellitus. J Clin Med. 2024;13:7005; https://doi.org/10.3390/jcm13237005
Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
© 2025 MJH Life Sciences

All rights reserved.